Back to top

Tale of the Tape

Zacks Equity Research

Earnings Estimates Moving Higher for Pluristem Therapeutics (PSTI): Time to Buy?
January 27, 2014


 ZacksTrade Now

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at or call 800-767-3771 ext.  9339.

Pluristem Therapeutics, Inc. (PSTI - Snapshot Report), a bio-therapeutics company, could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.   

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on PSTI’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Pluristem Therapeutics could be a solid choice for investors.     

Current Quarter Estimates for PSTI

Though there has been no upward or downward revision for Pluristem Therapeutics in the past 30 days, consensus estimate trend has been favorable for the company. Estimates have narrowed from a loss of 14 cents a share 30 days ago, to a loss of 13 cents today, a move of 7.1%.  

Current Year Estimates for PSTI

Meanwhile, Pluristem Therapeutics’s current year figures are also looking quite promising. Though there has been no upward or downward revision for the company in the past month, consensus estimate trend has seen a boost for this time frame. Estimates have narrowed from a loss of 61 cents a share 30 days ago, to a loss of 54 cents today, a move of 11.5%.    

Bottom Line

The stock has also started to move higher lately, adding 27.5% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #3 (Hold) stock to profit in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GRP IN DXYN 15.84 +7.90%
BOFI HLDG IN BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%